Lixte Biotechnology Holdings’ $5.7 Million Offering of Common Stock and Warrants

Ambrogio Visconti

Sheppard Mullin advised WestPark Capital, Inc. and WallchBeth Capital LLC on the deal. Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: Common stock – LIXT;…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now